Table 1 HSP70-2 expression (RT-PCR/IHC) and clinico-pathologic characteristics of breast cancer
From: Heat shock protein 70-2 (HSP70-2) overexpression in breast cancer
Pathologic and clinical features | RT-PCR (%) | IHC (%) | P value |
|---|---|---|---|
All tumors | 128/154 (83) | 128/154 (83) | 0.569 |
 Histotypes | |||
  DCIS | 8/8 (100) | 8/8 (100) |  |
  IDC | 116/139 (83.4) | 116/139 (83.4) |  |
  ILC | 4/5 (80) | 4/5 (80) |  |
  DCIS + IDC | 2/2 (100) | 2/2 (100) |  |
 Tumor stages (IDC) | |||
  Stage I | 3/3 (100) | 3/3 (100) |  |
  Stage II | 68/85 (80) | 68/85 (80) | 0.388 |
  Stage III | 39/45 (86.7) | 39/45 (86.7) | 0.343 |
  Stage IV | 6/6 (100) | 6/6 (100) | 0.341 |
  Stages | |||
   Early Stages (I + II) | 71/88 (80.7) | 71/88 (80.7) | 0.248 |
   Late Stages (III + IV) | 45/51 (88.2) | 45/51 (88.2) |  |
 Grades | |||
  Grade 1 | 62/69 (89.8) | 62/69 (89.8) |  |
  Grade 2 | 39/52 (75) | 39/52 (75) | 0.029* |
  Grade 3 | 15/18 (83.3) | 15/18 (83.3) | 0.468 |
 Lymph node involvement | |||
  Positive | 40/51 (78.4) | 40/51 (78.4) |  |
  Negative | 76/88 (86.4) | 76/88 (86.4) |  |